Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials.
作者信息
Hsueh Chung-Tsen, Liu Delong, Wang Hong
机构信息
New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA.
出版信息
Biomark Res. 2013 Jan 16;1(1):1. doi: 10.1186/2050-7771-1-1.
Abstract
摘要
相似文献
1
Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials.
Biomark Res. 2013 Jan 16;1(1):1. doi: 10.1186/2050-7771-1-1.
2
Relevance of Prognostic Factors in the Era of Targeted Therapies in CLL.
Curr Hematol Malig Rep. 2019 Aug;14(4):302-309. doi: 10.1007/s11899-019-00511-1.
3
Novel biomarkers for the diagnosis and prognosis of gallbladder cancer.
J Dig Dis. 2021 Feb;22(2):62-71. doi: 10.1111/1751-2980.12966.
4
Integrating biomarkers in clinical trials.
Expert Rev Mol Diagn. 2011 Mar;11(2):171-82. doi: 10.1586/erm.10.120.
5
Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review.
Surg Oncol. 2019 Dec;31:83-89. doi: 10.1016/j.suronc.2019.09.006. Epub 2019 Sep 13.
6
Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Genomics Proteomics Bioinformatics. 2017 Aug;15(4):220-235. doi: 10.1016/j.gpb.2016.11.005. Epub 2017 Aug 13.
7
A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma.
Cancer Treat Rev. 2014 May;40(4):533-47. doi: 10.1016/j.ctrv.2013.11.008. Epub 2013 Dec 4.
8
Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemia.
Leuk Lymphoma. 2021 Jun;62(6):1289-1301. doi: 10.1080/10428194.2020.1869966. Epub 2021 Jan 7.
9
Targeting claudins in cancer: diagnosis, prognosis and therapy.
Am J Cancer Res. 2021 Jul 15;11(7):3406-3424. eCollection 2021.
10
Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications.
Semin Cancer Biol. 2018 Oct;52(Pt 1):85-102. doi: 10.1016/j.semcancer.2017.07.004. Epub 2017 Jul 31.
引用本文的文献
1
Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies.
Front Oncol. 2020 Apr 21;10:536. doi: 10.3389/fonc.2020.00536. eCollection 2020.
2
A new role of C-Choline PET in localizing the epileptogenic foci in insular cortex in the patients.
CNS Neurosci Ther. 2020 Jan;26(1):144-147. doi: 10.1111/cns.13215. Epub 2019 Sep 11.
3
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis.
Cell Mol Life Sci. 2019 May;76(10):1833-1863. doi: 10.1007/s00018-019-03040-5. Epub 2019 Feb 15.
4
Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors.
ChemMedChem. 2019 Mar 22;14(6):615-620. doi: 10.1002/cmdc.201900019. Epub 2019 Feb 19.
5
Pharmacology of Pimasertib, A Selective MEK1/2 Inhibitor.
Eur J Drug Metab Pharmacokinet. 2018 Aug;43(4):373-382. doi: 10.1007/s13318-018-0466-x.
6
A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data.
Pragmat Obs Res. 2017 Aug 26;8:149-155. doi: 10.2147/POR.S140579. eCollection 2017.
7
A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase Family.
ACS Chem Biol. 2017 May 19;12(5):1245-1256. doi: 10.1021/acschembio.6b01060. Epub 2017 Mar 20.
8
B-Raf and the inhibitors: from bench to bedside.
J Hematol Oncol. 2013 Apr 25;6:30. doi: 10.1186/1756-8722-6-30.
9
MEK and the inhibitors: from bench to bedside.
J Hematol Oncol. 2013 Apr 12;6:27. doi: 10.1186/1756-8722-6-27.
本文引用的文献
1
Current management and prognostic features for gastrointestinal stromal tumor (GIST).
Exp Hematol Oncol. 2012 Jun 18;1(1):14. doi: 10.1186/2162-3619-1-14.
2
Recent advances and novel agents for gastrointestinal stromal tumor (GIST).
J Hematol Oncol. 2012 May 8;5:21. doi: 10.1186/1756-8722-5-21.
3
Current management and novel agents for malignant melanoma.
J Hematol Oncol. 2012 Feb 14;5:3. doi: 10.1186/1756-8722-5-3.
4
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5.
5
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5.
Zotero 插件